• Over 40 Years' Experience
• Board Certified Doctors
• Over 40 Years' Experience
• Board Certified Doctors
• Telemedicine Virtual Visits
Age Group | Medication | Age | Duration |
---|---|---|---|
Adult Moderate/Severe Asthma | Open Label Long Term Dupixent Study | 18 years and older | 3 years |
Adolescent/Adult Moderate Severe Asthma | Tezepelumab Open Label Study | 12 years and older | 1 year |
Age Group | Medication | Age | Duration |
---|---|---|---|
Pediatric/Adolescent | Lebrikizumab | 6 months - 17 years | 26 weeks |
Age Group | Medication | Age | Duration |
---|---|---|---|
Adult | Anti-Kit Antibody (Barzolvolimab). Short placebo arm followed by open label | 18 years and up | ~1 year |
Age Group | Medication | Age | Duration |
---|---|---|---|
Pediatric | Peanut Protein Patch Immunotherapy | 4 years - 7 years | ~1 year |
Age Group | Medication | Age | Duration |
---|---|---|---|
Adult | Medication - extract of 13 grass pollens. Patients will receive 6 injections outside of the grass pollen season | 18 - 65 years old | ~ 7 Months |
To learn more about patient privacy, click here to read our HIPAA Notice.
Share On: